Key Takeaways Two Active Ingredients, Five Products GLP-1 Market Represents a Financialized Business Model Prolonged Patent Protection & Market Exclusivity Two Active Ingredients, Five Products: Semaglutide is marketed by Novo Nordisk as three separate drug products under the brand names: Ozempic (injection for diabetes, approved in 2017), Rybelsus (oral tablet for diabetes, approved in 2019), and Wegovy (injection for weight loss, approved in 2021)
This was accompanied by the instruction to increase their physical activities and also receive the first Semaglutide dose
Most doctors say limit or avoid it
Semaglutide does not stop working
Several reasons could explain why your Wegovy shot hurts: Injection Site Sensitivity: Areas like the thigh or the outer part of the upper arm may have more nerve endings or less fat, making them more sensitive to injection
Please wait while your request is being verified...